Results

Total Results: over 10,000 records

Showing results for "drugs".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-bone-fracture_research-protocol.pdf
    May 14, 2010 - number of agents are currently available to treat osteoporosis, including the bisphosphonate class of drugs … Controlled clinical trials that report fracture outcomes for one or more of the drugs of interest will … In our search to identify clinical studies of drugs of interest to this review, we will use terms for … osteoporosis, osteopenia, low bone density, and the drugs listed in the key questions (as well as any … In our search for the key AE, we will use terms for the AE and each of the drugs of interest for this
  2. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
    March 01, 2012 - for development of exenatide, leaving sole development responsibility to Amylin Pharmaceuticals. … No major hypoglycemia events occurred. 47 In July 2011, Amylin Pharmaceuticals, Eli Lilly, and … Drugs Future 2008;33(9):745-51. 74. … Selected pharmaceuticals in late stage U.S. and E.U. development or registration. … The Woodlands (TX): Lexicon Pharmaceuticals; [accessed 2011 May 23]. [1 p].
  3. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49728/psn-pdf
    March 01, 2015 - The Commentary With the ever-growing number of marketed drugs, the potential for look-alike and sound-alike … Similar sounding drugs typically appear near each other on computer selection screens, often with similar … Although it is difficult to know the percentage of medication errors associated with LASA drugs, a rate … Best Practices in Developing Proprietary Names for Drugs: Draft Guidance. … pubmed/25025346 http://ismp.org/Newsletters/acutecare/articles/19960731.asp http://www.fda.gov/downloads/Drugs
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND__0250_05-20-2010.pdf
    January 01, 2010 - Staff-Generated PICO: Treatment of Atrial Fibrillation Population(s): Adults with AF Intervention(s): Drugs … There are several drugs, devices, and procedures used for the treatment of atrial fibrillation. … In recent years, technological advancements, new marketed drugs, and new therapeutic considerations
  5. psnet.ahrq.gov/issue/administering-just-diluent-or-one-two-vaccine-components-leaves-patients-unprotected
    May 07, 2018 - November 5, 2014 A mislabeling event with batched drugs: the unintended consequences … March 26, 2014 Audit of missed or delayed antimicrobial drugs.
  6. psnet.ahrq.gov/issue/eliminating-insulin-errors-rphs-share-tricks
    June 13, 2011 - April 6, 2022 Cardiovascular drugs: linked to many errors. … October 5, 2005 Cardiovascular drugs: linked to many errors.
  7. psnet.ahrq.gov/issue/ismps-list-confused-drug-names
    August 21, 2015 - Look-alike, sound-alike drugs. … Health Care Providers Health Care Executives and Administrators Look-Alike, Sound-Alike Drugs
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/allergy-seasonal_executive.pdf
    July 01, 2013 - Six classes of drugs and nasal saline are used to treat SAR. … • Corticosteroids are potent anti-inflammatory drugs. … conclusions generalize to other drugs in the same class is uncertain. … • We included FDA-approved drugs only. … effects of other drugs.
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-high-risk-drugs-rapid-response.pdf
    January 01, 2024 - Making Healthcare Safer IV_Rapid Response: Reducing Adverse Drug Events Related to Anticoagulant Use in Adults Making Healthcare Safer IV Reducing Adverse Drug Events Related to Anticoagulant Use in Adults Rapid Response Main Points 1. Anticoagulation medications help prevent life-threatening events such…
  10. psnet.ahrq.gov/issue/tragic-error-neuromuscular-blocker-should-prompt-risk-assessment-all-hospitals
    November 16, 2015 - November 5, 2014 A mislabeling event with batched drugs: the unintended consequences … Departments Health Care Providers Emergency Medicine Hospital Pharmacy Specific to High-Risk Drugs
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/urinary-incontinence-treatment_research-protocol.pdf
    September 30, 2010 - Adverse events resulting from drugs. 2. … Adrenergic drugs for urinary incontinence in adults. … Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. … Anticholinergic drugs versus other medications for overactive bladder syndrome in adults. … delirium/confusional state; urinary tract infection (symptomatic); atrophic urethritis/vaginitis; use of pharmaceuticals
  12. www.uspreventiveservicestaskforce.org/home/getfilebytoken/5W2k4HLBPLPgHov6sSvuMH
    July 24, 2018 - Government of Canada website. https://www.canada.ca/en/public-health/ services/publications/drugs-health-products … dx.doi.org/10.1056/NEJM198903233201204 https://www.canada.ca/en/public-health/services/publications/drugs-health-products … national-surveillance-antimicrobial-susceptibilities-neisseria-gonorrhoeae-annual-summary-2015.html https://www.canada.ca/en/public-health/services/publications/drugs-health-products … national-surveillance-antimicrobial-susceptibilities-neisseria-gonorrhoeae-annual-summary-2015.html https://www.canada.ca/en/public-health/services/publications/drugs-health-products … national-surveillance-antimicrobial-susceptibilities-neisseria-gonorrhoeae-annual-summary-2015.html https://www.canada.ca/en/public-health/services/publications/drugs-health-products
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
    March 01, 2012 - Pharmacologic agents include the bisphosphonate class of drugs, peptide hormones (parathyroid hormone … that had been rejected on the basis of drugs that were now included within the scope of the update … indicated for the treatment of osteoporosis (but not if the drugs were being used to treat cancer); … , and single drug versus single drug comparisons for drugs within the same class and across classes … • How was exposure to drugs/exercise ascertained?
  14. psnet.ahrq.gov/issue/medication-safety-issue-brief-bar-code-implementation-strategies
    June 17, 2014 - Look-alike, sound-alike drugs. … December 12, 2012 Impact of interactions between drugs and laboratory test results on
  15. psnet.ahrq.gov/issue/recommendations-practitioners-and-manufacturers-address-system-based-causes-vaccine-errors
    June 18, 2014 - June 4, 2014 Audit of missed or delayed antimicrobial drugs. … December 15, 2010 Cardiovascular drugs: linked to many errors.
  16. psnet.ahrq.gov/issue/metric-units-and-preferred-dosing-orally-administered-liquid-medications
    April 11, 2011 - Copy URL July 3, 2016 Neville K, Galinkin JL, Green TP, et al; Committee on Drugs … January 11, 2017 Key potentially inappropriate drugs in pediatrics: the KIDs list.
  17. psnet.ahrq.gov/issue/unverified-patient-reported-error-false-alarm-can-have-real-consequences
    June 05, 2018 - May 7, 2014 A mislabeling event with batched drugs: the unintended consequences of practice … February 19, 2014 Survey suggests possible downward trend in identifying key drugs/drug
  18. digital.ahrq.gov/sites/default/files/docs/citation/r21hs022927-primack-final-report-2017.pdf
    January 01, 2017 - non-EBP) in the United States are multifaceted, the multi-billion-dollar marketing of prescription drugsDrugs: safe use initative fact sheet. … United States, 2014. http://www.fda.gov/Drugs/DrugSafety/ucm188760.htm. … A decade of direct-to-consumer advertising of prescription drugs. … Direct-to-consumer advertising of pharmaceuticals. Am J Med 2007; 120: 475–80.
  19. psnet.ahrq.gov/web-mm/novel-drug-misuse
    September 30, 2010 - that the commentary does not include information about or discuss investigational or off-label use of pharmaceuticalproducts or medical devices. … addition, the commentary does not include information regarding investigational or off-label use of pharmaceuticalproducts or medical devices. … July 14, 2010 Adverse events associated with sedatives, analgesics, and other drugs that
  20. digital.ahrq.gov/sites/default/files/docs/citation/enhancedmedhistories_102611comp.pdf
    October 01, 2011 - Reminder rates for elderly patients taking at least two drugs from the list of “Drugs to Avoid in … But as may be seen from Table 20 and 21, drugs from the HEDIS list of “Drugs to Avoid in the Elderly … Reminder rates for elderly patients taking at least two drugs from the list of “Drugs to Avoid in the … most frequent Drugs to Avoid in the Elderly. … Drugs To Be Avoided in the Elderly Category 5.